evertex fabrinology limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 602.77 million compared to TWD 571.9 million a year ago. Revenue was TWD 845.15 million compared to TWD 894.79 million a year ago.

Net income was TWD 32.84 million compared to TWD 65.2 million a year ago. Basic earnings per share from continuing operations was TWD 0.38 compared to TWD 0.76 a year ago. Diluted earnings per share from continuing operations was TWD 0.38 compared to TWD 0.76 a year ago.